 insulin and other drugs. This lawsuit is expected to target those so-called middlemen that pushed patients to more expensive insulin. Lawmakers and federal regulators accused drug makers of inflating the price of the drug. Politico reports United Health Group, CVS and Cigna are all expected to face lawsuits. Now they represent about 80 percent of prescriptions here in the U.S.